Outcomes Research Teams Receive Poster Presentation Awards at ISPOR

June 12, 2014

Several members of Analysis Group's Health Care practice were recognized for their participation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting in Montreal, Quebec, May 31--June 4, 2014.

A consultant team received an award for the best poster at the meeting. The team -- including Analysis Group Managers Brad Rice and Noam Kirson, Associate Amie Shei, Analyst Caroline Enloe, Senior Analyst Alice Kate Cummings, and Principal Howard Birnbaum, as well as Rami Ben-Joseph, head of health outcomes and pharmacoeconomics at Purdue Pharma -- presented the research poster "The Burden of Opioid Abuse among Commercially Insured Patients." This and a related poster presentation drew from research conducted by Analysis Group and was supported by Purdue Pharma.

In addition, the poster "Cost-effectiveness of Adalimumab for the Treatment of Moderately to Severely Active Ulcerative Colitis in Canada" was selected as a best poster finalist. The poster was presented by a research team that included Analysis Group Manager Hongbo Yang and Associate Min Yang, as well as other researchers.

In total, Analysis Group consultants and colleagues delivered one podium presentation and exhibited 27 posters focused on cost-of-illness and comparative effectiveness studies targeting hepatitis C, acute coronary syndrome, multiple sclerosis, sickle cell disease, HIV, hemophilia, schizophrenia, opioid abuse, and lung cancer, as well as health care resource utilization in the United States, Canada, and China.

Read more about our presence at the 2014 ISPOR Conference